Loading…
Sinopharm's subsidiary China Medical Equipment and Qingdao Hitex New Light signed a memorandum on December 6, 2021, to form a joint venture with a registered capital of CNY 160 million, with Sinopharm holding 51% and Hitex 49%, to develop and sell medical endoscopes.
“国药器械及海泰新光拟以现金出资方式按51:49的比例设立合资公司,合资公司注册资本总额为人民币1.6亿元。”beta.zhitongcaijing.com
Summarized from public sources; check the original articles before acting on it.